Literature DB >> 19762381

Class IV-G and IV-S lupus nephritis in Chinese patients: a large cohort study from a single center.

F Yu1, Y Tan, L-H Wu, S-N Zhu, G Liu, M-H Zhao.   

Abstract

This study is to assess the difference between IV-G and IV-S in a large cohort of Chinese patients with lupus nephritis. The detailed data of patients with subclass IV-G and IV-S were retrospectively analyzed. Serum ANCA and anti-C1q antibodies were detected. A total of 172 cases were classified as class IV, including 152 cases with IV-G and 20 cases with IV-S. In IV-S, the level of haemoglobin was significantly higher (P = 0.024), proteinuria was milder (P = 0.003), serum creatinine was lower (P = 0.021), serum C3 was higher (P = 0.045) and the ratio of positive serum anti-cardiolipin antibodies was higher (P = 0.014). On pathological evaluation, the ratio of glomerular fibrinoid necrosis was significantly higher (P = 0.006) and the score of endocapillary hypercellualrity, interstitial inflammation and total activity indices was significantly lower (P < 0.001, P = 0.01, P = 0.006, respectively) in IV-S. The frequency of serum ANCA was significantly higher in IV-S than that in IV-G (20 vs 4.6%, P = 0.008). The frequencies of anti-C1q IgG1 and IgG3 subclass were significantly higher in IV-G (P = 0.006, P = 0.011, respectively). There are significant differences in clinical and pathological manifestations between IV-S and IV-G lupus nephritis which need further investigation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19762381     DOI: 10.1177/0961203309106795

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  11 in total

1.  Segmental and global subclasses of class IV lupus nephritis have similar renal outcomes.

Authors:  Catharina M Haring; Anke Rietveld; Jan A J G van den Brand; Jo H M Berden
Journal:  J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 10.121

Review 2.  Redefining lupus nephritis: clinical implications of pathophysiologic subtypes.

Authors:  Feng Yu; Mark Haas; Richard Glassock; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

3.  Characteristics and influence factors of pathologic transformation in the subclasses of class IV lupus nephritis.

Authors:  Jian-jun Gao; Guang-yan Cai; Shu-wen Liu; Li Tang; Xue-guang Zhang; Yang Yang; Pu Chen; Shu-xin Liu; Jia-yao Ji; Suo-zhu Shi; Zhong Yin; Xiang-mei Chen
Journal:  Rheumatol Int       Date:  2011-03-26       Impact factor: 2.631

4.  Clinical and Histopathologic Characteristics Associated with Renal Outcomes in Lupus Nephritis.

Authors:  Emilie C Rijnink; Y K Onno Teng; Suzanne Wilhelmus; Mathilde Almekinders; Ron Wolterbeek; Karlien Cransberg; Jan A Bruijn; Ingeborg M Bajema
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-04       Impact factor: 8.237

5.  Long-term renal outcomes of childhood-onset global and segmental diffuse proliferative lupus nephritis.

Authors:  Pornpimol Rianthavorn; Athitaya Buddhasri
Journal:  Pediatr Nephrol       Date:  2015-06-09       Impact factor: 3.714

Review 6.  Clinicopathological insights into lupus glomerulonephritis in Japanese and Asians.

Authors:  Hitoshi Yokoyama; Hiroshi Okuyama; Hideki Yamaya
Journal:  Clin Exp Nephrol       Date:  2011-03-25       Impact factor: 2.801

7.  Clinicopathological correlation in asian patients with biopsy-proven lupus nephritis.

Authors:  Bancha Satirapoj; Pamila Tasanavipas; Ouppatham Supasyndh
Journal:  Int J Nephrol       Date:  2015-03-19

8.  A clinicopathological study on lupus nephritis; experience of 34 cases from Bangladesh.

Authors:  Muhammad Nazmul Baqui; Shabnam Akhter; Enamul Kabir; Mohammad Shamiul Islam
Journal:  J Nephropharmacol       Date:  2015-07-22

9.  A Predictive Model for Estimation Risk of Proliferative Lupus Nephritis.

Authors:  Dong-Ni Chen; Li Fan; Yu-Xi Wu; Qian Zhou; Wei Chen; Xue-Qing Yu
Journal:  Chin Med J (Engl)       Date:  2018-06-05       Impact factor: 2.628

10.  ISN/RPS 2003 classification of lupus nephritis: time to take a look on the achievements and limitations of the schema.

Authors:  Muhammed Mubarak; Hamid Nasri
Journal:  J Nephropathol       Date:  2014-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.